Skip to main content
Top
Published in: Clinical and Experimental Nephrology 5/2011

01-10-2011 | Case Report

Fanconi–Bickel syndrome in a 3-year-old Indian boy with a novel mutation in the GLUT2 gene

Authors: Arun Gopalakrishnan, Manish Kumar, Sriram Krishnamurthy, Osamu Sakamoto, Sadagopan Srinivasan

Published in: Clinical and Experimental Nephrology | Issue 5/2011

Login to get access

Abstract

Fanconi–Bickel syndrome is a rare autosomal recessive disorder characterized by hepatorenal glycogen accumulation, proximal renal tubular dysfunction and impaired utilization of glucose and galactose. Most cases have been reported from Europe, Japan, Turkey and the Mediterranean belt. We report a 3-year-old boy from southern India who presented with doll-like facies, florid rickets, massive hepatomegaly, growth retardation, renomegaly and laboratory evidence of proximal renal tubular dysfunction. Liver biopsy demonstrated evidence of glycogenosis. Direct sequencing of genomic DNA confirmed a diagnosis of Fanconi–Bickel syndrome, revealing a G-to-A substitution at position −1 of the splicing acceptor site in intron 1 of the GLUT2 gene in a homozygous pattern (c.16-1G>A or IVS1-1G>A). This novel mutation has not been described in earlier studies. The child was treated with oral potassium citrate, oral phosphorus supplementation, and alpha-calcitriol, on which metabolic derangements were corrected.
Literature
1.
go back to reference Santer R, Schneppenheim R, Suter D, Schaub J, Steinmann B. Fanconi–Bickel syndrome—the original patient and his natural history, historical steps leading to the primary defect, and a review of the literature. Eur J Pediatr. 1998;157:783–97.CrossRefPubMed Santer R, Schneppenheim R, Suter D, Schaub J, Steinmann B. Fanconi–Bickel syndrome—the original patient and his natural history, historical steps leading to the primary defect, and a review of the literature. Eur J Pediatr. 1998;157:783–97.CrossRefPubMed
2.
go back to reference Santer R, Steinmann B, Schaub J. Fanconi–Bickel syndrome—a congenital defect of facilitative glucose transport. Curr Mol Med. 2002;2:213–27.CrossRefPubMed Santer R, Steinmann B, Schaub J. Fanconi–Bickel syndrome—a congenital defect of facilitative glucose transport. Curr Mol Med. 2002;2:213–27.CrossRefPubMed
3.
go back to reference Konus OL, Ozdemir A, Akkaya A, Erbas G, Celik H, Isik S. Normal liver, spleen, and kidney dimensions in neonates, infants, and children: evaluation with sonography. Am J Roentgenol. 1998;171:1693–8.CrossRef Konus OL, Ozdemir A, Akkaya A, Erbas G, Celik H, Isik S. Normal liver, spleen, and kidney dimensions in neonates, infants, and children: evaluation with sonography. Am J Roentgenol. 1998;171:1693–8.CrossRef
4.
go back to reference Manz F, Bickel H, Brodehl J, Feist D, Gellissen K, Gescholl-Bauer B, et al. Fanconi–Bickel syndrome. Pediatr Nephrol. 1987;1:509–18.CrossRefPubMed Manz F, Bickel H, Brodehl J, Feist D, Gellissen K, Gescholl-Bauer B, et al. Fanconi–Bickel syndrome. Pediatr Nephrol. 1987;1:509–18.CrossRefPubMed
5.
go back to reference Fanconi G, Bickel H. Die chronische Aminoacidurie (Aminosaeurediabetes oder nephrotischglukosurischer Zwergwuchs) bei der Glykogenose und der Cystinkrankheit. Helv Pediat Acta. 1949;4:359–96. Fanconi G, Bickel H. Die chronische Aminoacidurie (Aminosaeurediabetes oder nephrotischglukosurischer Zwergwuchs) bei der Glykogenose und der Cystinkrankheit. Helv Pediat Acta. 1949;4:359–96.
6.
go back to reference Pascual JM. Glucose transport hereditary diseases. Med Clin (Barc). 2006;127:709–14.CrossRef Pascual JM. Glucose transport hereditary diseases. Med Clin (Barc). 2006;127:709–14.CrossRef
7.
go back to reference Leturque A, Brot-Laroche E, Le Gall M. GLUT2 mutations, translocation, and receptor function in diet sugar managing. Am J Physiol Endocrinol Metab. 2009;296:e985–92.CrossRefPubMed Leturque A, Brot-Laroche E, Le Gall M. GLUT2 mutations, translocation, and receptor function in diet sugar managing. Am J Physiol Endocrinol Metab. 2009;296:e985–92.CrossRefPubMed
8.
go back to reference Santer R, Groth S, Kinner M, Dombrowski A, Berry GT, Brodehl J, et al. The mutation spectrum of the facilitative glucose transporter gene SLC2A2 (GLUT2) in patients with Fanconi–Bickel syndrome. Hum Genet. 2002;110:21–9.CrossRefPubMed Santer R, Groth S, Kinner M, Dombrowski A, Berry GT, Brodehl J, et al. The mutation spectrum of the facilitative glucose transporter gene SLC2A2 (GLUT2) in patients with Fanconi–Bickel syndrome. Hum Genet. 2002;110:21–9.CrossRefPubMed
10.
go back to reference Şimşek E, Savaş-Erdeve S, Sakamoto O, Doğancı T, Dallar Y. A novel mutation of the GLUT2 gene in a Turkish patient with Fanconi–Bickel syndrome. Turk J Pediatr. 2009;51:166–8.PubMed Şimşek E, Savaş-Erdeve S, Sakamoto O, Doğancı T, Dallar Y. A novel mutation of the GLUT2 gene in a Turkish patient with Fanconi–Bickel syndrome. Turk J Pediatr. 2009;51:166–8.PubMed
11.
go back to reference Akagi M, Inui K, Nakajima S, Shima M, Nishigaki T, Muramatsu T, et al. Mutation analysis of two Japanese patients with Fanconi–Bickel syndrome. J Hum Genet. 2000;45:60–2.CrossRefPubMed Akagi M, Inui K, Nakajima S, Shima M, Nishigaki T, Muramatsu T, et al. Mutation analysis of two Japanese patients with Fanconi–Bickel syndrome. J Hum Genet. 2000;45:60–2.CrossRefPubMed
12.
go back to reference Ozer EA, Aksu N, Uclar E, Erdogan H, Bakiler AR, Tsuda M, et al. No mutation in the SLC2A2 (GLUT2) gene in a Turkish infant with Fanconi–Bickel syndrome. Pediatr Nephrol. 2003;18:397–8.PubMed Ozer EA, Aksu N, Uclar E, Erdogan H, Bakiler AR, Tsuda M, et al. No mutation in the SLC2A2 (GLUT2) gene in a Turkish infant with Fanconi–Bickel syndrome. Pediatr Nephrol. 2003;18:397–8.PubMed
13.
go back to reference Shapiro MB, Senapathy P. RNA splice junctions of different classes of eukaryotes: sequence statistics and functional implications in gene expression. Nucleic Acids Res. 1987;15:7155–74.CrossRefPubMedPubMedCentral Shapiro MB, Senapathy P. RNA splice junctions of different classes of eukaryotes: sequence statistics and functional implications in gene expression. Nucleic Acids Res. 1987;15:7155–74.CrossRefPubMedPubMedCentral
14.
go back to reference Karande S, Kumbhare N, Kulkarni M. Fanconi–Bickel syndrome. Indian Pediatr. 2007;44:223–5.PubMed Karande S, Kumbhare N, Kulkarni M. Fanconi–Bickel syndrome. Indian Pediatr. 2007;44:223–5.PubMed
15.
go back to reference Mohandas Nair K, Sakamoto O, Jagadeesh S, Nampoothiri S. Fanconi–Bickel syndrome. Indian J Pediatr. 2011 (Epub ahead of print). Mohandas Nair K, Sakamoto O, Jagadeesh S, Nampoothiri S. Fanconi–Bickel syndrome. Indian J Pediatr. 2011 (Epub ahead of print).
16.
go back to reference Wang LY, Fasulo D. A fast boosting-based screening method for large scale association study in complex traits with genetic heterogeneity. Conf Proc IEEE Eng Med Biol Soc. 2006;1:5771–4.PubMed Wang LY, Fasulo D. A fast boosting-based screening method for large scale association study in complex traits with genetic heterogeneity. Conf Proc IEEE Eng Med Biol Soc. 2006;1:5771–4.PubMed
Metadata
Title
Fanconi–Bickel syndrome in a 3-year-old Indian boy with a novel mutation in the GLUT2 gene
Authors
Arun Gopalakrishnan
Manish Kumar
Sriram Krishnamurthy
Osamu Sakamoto
Sadagopan Srinivasan
Publication date
01-10-2011
Publisher
Springer Japan
Published in
Clinical and Experimental Nephrology / Issue 5/2011
Print ISSN: 1342-1751
Electronic ISSN: 1437-7799
DOI
https://doi.org/10.1007/s10157-011-0456-7

Other articles of this Issue 5/2011

Clinical and Experimental Nephrology 5/2011 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.